Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors
摘要:
Pyrrolo[2,1-f][1,2,4] triazine based inhibitors of p38 alpha have been prepared exploring functional group modifications at the C6 position. Incorporation of aryl and heteroaryl ketones at this position led to potent inhibitors with efficacy in in vivo models of acute and chronic inflammation. (C) 2011 Elsevier Ltd. All rights reserved.
Pyrrolo-triazine aniline compounds useful as kinase inhibitors
申请人:Dyckman Alaric
公开号:US20070043053A1
公开(公告)日:2007-02-22
Compounds having the formula (I),
and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, X and Z are as described in the specification.
Pyrrolo-Triazine Aniline Compounds Useful As Kinase Inhibitors
申请人:Dyckman Alaric
公开号:US20090105243A1
公开(公告)日:2009-04-23
Compounds having the formula (I),
and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, X and Z are as described in the specification.
PYRROLO-TRIAZINE ANILINE COMPOUNDS USEFUL AS KINASE INHIBITORS
申请人:Dyckman Alaric
公开号:US20100240646A1
公开(公告)日:2010-09-23
Compounds having the formula (I),
and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, X and Z are as described in the specification.